Bright Minds Biosciences Inc.DRUGNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank4
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P4
Near historical low
vs 2Y Ago
-11.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-358.66%
Q3 202563.81%
Q2 2025-44.48%
Q1 2025-62.29%
Q4 2024-222.64%
Q3 2024-292.86%
Q2 2024129.83%
Q1 20242.07%
Q4 202331.35%
Q3 202327.45%
Q2 2023-9.13%
Q1 202343.22%
Q4 2022-25.14%
Q3 202225.63%
Q2 202221.49%
Q1 202226.37%
Q4 2021-107.19%
Q3 202119.62%
Q2 2021-111.21%
Q1 2021-156.13%
Q4 2020-160.89%
Q3 2020-1164.06%
Q2 2020152.34%
Q1 202036.68%
Q4 20190.00%